Line K. Vibholm
Arhus, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Immunological dysfunction associated with SARS-CoV-2 persistence in immunocompromised patients.
Journal: Clinical and experimental immunology
Published: September 11, 2025
Examination of autoantibodies to type I interferon in patients suffering from long COVID.
Journal: Journal of medical virology
Published: July 04, 2023
High-dose coenzyme Q10 therapy versus placebo in patients with post COVID-19 condition: a randomized, phase 2, crossover trial.
Journal: The Lancet regional health. Europe
Published: August 08, 2022
CD169 (Siglec-1) as a Robust Human Cell Biomarker of Toll-Like Receptor 9 Agonist Immunotherapy.
Journal: Frontiers in cellular and infection microbiology
Published: April 13, 2022
The Impact of IFNλ4 on the Adaptive Immune Response to SARS-CoV-2 Infection.
Journal: Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research
Published: November 17, 2021
Persistent Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Immunocompromised Host Displaying Treatment Induced Viral Evolution.
Journal: Open forum infectious diseases
Published: April 06, 2021
SARS-CoV-2 elicits robust adaptive immune responses regardless of disease severity.
Journal: EBioMedicine
Published: March 04, 2021
SARS-CoV-2 persistence is associated with antigen-specific CD8 T-cell responses.
Journal: EBioMedicine
Published: November 16, 2020
TLR9 agonist MGN1703 enhances B cell differentiation and function in lymph nodes.
Journal: EBioMedicine
Published: May 01, 2019
Last Updated: 09/26/2026